Prediction of Dietary Intervention Efficacy in Mild Ulcerative Colitis Patients Based on Fecal Microbiome Signatures
NCT05579483 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2023-04-26
Summary
A double-blind randomized placebo-controlled parallel trial with two intervention arms and two placebo arms and a period of eight intervention weeks to validate the prediction that prebiotics could induce a higher response in mild UC patients with certain fecal microbiome signatures.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Prebiotics
The prebiotics consists of three non-digestible carbohydrates (40% acacia gum, 20% partially hydrolyzed guar gum, and 40% resistant starch). During the 8-week intervention, two sachets (3 g per sachet) will be consumed per day, one in the morning and one in the evening.
- DIETARY_SUPPLEMENT
-
Placebo
The placebo consists of two digestible carbohydrates (20% maltodextrin and 80% corn starch). During the 8-week intervention, two sachets (3 g per sachet) will be consumed per day, one in the morning and one in the evening.
Sponsors & Collaborators
-
Winclove Probiotics B.V.
collaborator INDUSTRY -
China Scholarship Council
collaborator UNKNOWN -
Wageningen University
lead OTHER
Principal Investigators
-
Erwin G Zoetendal, PhD · Laboratory of Microbiology, Wageningen University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-12-31
- Primary Completion
- 2024-10-31
- Completion
- 2025-10-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Feasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative Colitis
NCT05743153 ·Status: UNKNOWN ·Phase: NA
-
R-3750 in Patients With Mild to Moderate Ulcerative Colitis
NCT05666960 ·Status: RECRUITING ·Phase: PHASE1
-
Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative Colitis
NCT02488954 ·Status: TERMINATED ·Phase: NA
-
The Effect of Diet on Disease Activity and Symptoms in Patients With Ulcerative Colitis
NCT03053713 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis
NCT01538251 ·Status: TERMINATED ·Phase: PHASE3
-
Faecal Microbiota Transplantation in Ulcerative Colitis
NCT01896635 ·Status: COMPLETED ·Phase: PHASE2
-
Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis
NCT03998488 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of ENC1018 Capsules in Patients With Moderate-to-severe Active Ulcerative Colitis (UC)
NCT07062185 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Impact of Fecal Microbiota Transplantation in Ulcerative Colitis
NCT03483246 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Lactobacillus Reuteri ATCC PTA 4659 in Ulcerative Colitis
NCT03798210 ·Status: UNKNOWN ·Phase: PHASE2
-
Restoration of the Microbiome Through Superdonor Selection
NCT03110289 ·Status: UNKNOWN ·Phase: NA
-
UC Cohort - The Influence of Diet on Gut Microbiotas
NCT04933162 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease
NCT05733845 ·Status: RECRUITING ·Phase: NA
-
Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for Colitis
NCT07047339 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
NCT06979336 ·Status: RECRUITING ·Phase: PHASE2
-
Metagenomic Analysis of Gut Microbiome in Korean Patients With Ulcerative Colitis
NCT01010815 ·Status: UNKNOWN
-
The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis
NCT02435160 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of Prebiotic FOS on Intestinal Abundance of Faecalibacterium Prausnitzii in Patients With Crohn´s Disease
NCT02539849 ·Status: COMPLETED ·Phase: NA
-
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
NCT02958865 ·Status: COMPLETED ·Phase: PHASE2
-
Fecal Transplant for Ulcerative Colitis
NCT03948919 ·Status: COMPLETED ·Phase: PHASE1
-
Standardized Fecal Microbiota Transplantation for Ulcerative Colitis
NCT01790061 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative Colitis
NCT02291523 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis
NCT02345733 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
NCT04033445 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Fecal Microbiota Transplantation (FMT) in the Management of Active Ulcerative Colitis
NCT02227342 ·Status: COMPLETED ·Phase: PHASE1/PHASE2